PYC-003

N/A

Report date: 2026/05/07 20:00:36

NME

Base Information

Drug NamePYC-003

Drug Alias NamePYC-003

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionPolycystin-1 stimulants

TargetsPolycystin-1

Therapy Area/IndicationsPolycystic Kidney, Autosomal DominantPolycystic Kidney Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew ZealandAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPYC Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesPYC Therapeutics LLC

Inactive CompaniesN/A

Active IndicationsPolycystic Kidney, Autosomal DominantPolycystic Kidney Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A